Amylin Pharmaceuticals has announced the launch of SymlinPen 120 and SymlinPen 60 pen-injector devices for administering Symlin (pramlintide acetate injection). SymlinPen 120 features fixed dosing to deliver 60 or 120 micrograms per dose and SymlinPen 60 features fixed dosing to deliver 15, 30, 45, or 60 micrograms per dose. Both pen-injector devices can be stored at room temperature after first use. Symlin is an amylin analogue/amylinomimetic indicated as an adjunct to mealtime insulin in adults with type 1 or type 2 diabetes.
For more information call (800) 349-8919 or visit www.symlin.com.